Hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial

Journal Title: Annals of Hepatology - Year 2009, Vol 8, Issue 1

Abstract

It is a comment of an article published in N Engl J Med. 2008;359:2429-41

Authors and Affiliations

Mazhar Haque, Eric Yoshida

Keywords

Related Articles

Pioglitazone upregulates hepatic angiotensin converting enzyme 2 expression in rats with steatohepatitis

Objective. Angiotensin II, one component of renin-angiotensin system (RAS), is formed from Ang I by the catalysing of angiotensin converting enzyme (ACE). Angiotensin II plays an important role in the development of insu...

Potential Molecular Targets of Statins in the Prevention of Hepatocarcinogenesis

Hepatocellular carcinoma (HCC) represents 90% of liver tumors. Statins, may reduce the incidence of various tumors, including HCC. Antitumoral activities may be mediated by changes in transforming growth factor-beta (TGF...

Non-neoplastic Portal Vein Thrombosis in HCV Cirrhosis Patients: Is it an Immuno-Inflammatory Disorder?

Background and aims. Portal vein thrombosis (PVT) is a critical complication in cirrhotic patients. We explored the role of the activated factor VII-antithrombin (FVIIa-AT) complex and enhanced monocytic tissue factor (T...

Serum cystatin C measurement in differential diagnosis of intra and extrahepatic cholestatic diseases

Objective. Cystatin C is a very potent inhibitor of cysteine proteinases and, it has been clinically applied as a sensitive marker in monitoring of renal and liver functions. The aim of this study was to reveal whether...

Download PDF file
  • EP ID EP77835
  • DOI -
  • Views 124
  • Downloads 0

How To Cite

Mazhar Haque, Eric Yoshida (2009). Hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial. Annals of Hepatology, 8(1), 78-78. https://europub.co.uk/articles/-A-77835